Programmed death 1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibitors are proved to be promising and are applied for the treatment of a variety of solid tumors. This retrospective study evaluated the efficacy of PD-1/PD-L1 inhibitors in patients with advanced solid tumors and explore the effect of clinical characteristics on it.

中文翻译：

---

PD-1/PD-L1抑制剂治疗晚期实体瘤疗效的临床观察

程序性死亡1（PD-1）/程序性死亡配体1（PD-L1）抑制剂被证明是有前景的，并被应用于治疗多种实体瘤。本回顾性研究评估了PD-1/PD-L1抑制剂对晚期实体瘤患者的疗效，并探讨临床特征对其的影响。